In-Vitro Diagnostic Substance Manufacturing

NAICS 325413

The U.S. In-Vitro Diagnostic Substance Manufacturing industry (NAICS 325413) and a workplace injury rate of 1.6 per 100 workers (2013). Data: BLS CES, JOLTS, and SOII.

Workplace Injuries (SOII, 2013)

Recordable injuries and incidence rate (per 100 workers) from BLS SOII.

Total Recordable Cases

400

Days Away from Work

100

Incidence Rate

1.6

per 100 workers

Full injury detail →

Producer Prices (PPI)

Latest PPI (Mar 2026): 303.9. Track the full series from BLS PPI.

Full PPI series →

Explore In-Vitro Diagnostic Substance Manufacturing

Related Industries

Other industries within NAICS sector 32.